Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Trusted oversight from TrimRx, ensuring each dose is managed properly
In Covid-19, inflammatory signaling pathways like NLRP3 inflammasome and NF-B are highly activated, leading to hyperinflammation and the development of cytokine storms
Technical Specifications Compound: Synthetic Tri-Agonist Peptide (Retatrutide) Format: Lyophilized research peptide kit Purity: 9899% (COA included) Appearance: White lyophilized powder Category: Research peptide reagent Included: Multiple vials (exact count based on your kit contents) Intended Use This kit is designed exclusively for: Laboratory research In-vitro experimentation Biochemical pathway modeling Peptide-receptor interaction studies Non-human preclinical research Academic and institutional scientific work Not intended for: Human or animal use Injection, ingestion, inhalation, or topical administration Medical, therapeutic, diagnostic, or health-related purposes This compound is not approved by Health Canada, FDA, or any regulatory body for clinical application
9, 840 (2019), Application(s): WB Human Brain Tissue, Abstract Full Text Air particulate matter SRM 1648a primes macrophages to hyperinflammatory response after LPS stimulation: Gawda, A., Majka, G., et al
Capsule is pre-loaded with a quantified amount of therapeutic drug
